Development and evaluation of cell membrane-based biomimetic nanoparticles loaded by Clostridium perfringens epsilon toxin: a novel vaccine delivery platform for Clostridial-associated diseases

References

• Alqahtani, S., L. Simon, C. E. Astete, A. Alayoubi, P. W. Sylvester, S. Nazzal, Y. Shen, Z. Xu, A. Kaddoumi, and C. M. Sabliov. 2015. “Cellular Uptake, Antioxidant and Antiproliferative Activity of Entrapped α-Tocopherol and γ-Tocotrienol in Poly (Lactic-co-Glycolic) Acid (PLGA) and Chitosan Covered PLGA Nanoparticles (PLGA-Chi).” Journal of Colloid and Interface Science 445: 243–251. https://doi.org/10.1016/j.jcis.2014.12.083
   PubMed Web of Science ®Google Scholar
• Altaf, S., F. Muhammad, B. Aslam, and M. Faisal. 2021. “Cell Membrane Enveloped Polymeric Nanosponge for Detoxification of Chlorpyrifos Poison: In Vitro and In Vivo Studies.” Human & Experimental Toxicology 40 (8): 1286–1295. https://doi.org/10.1177/0960327121993207
   PubMed Web of Science ®Google Scholar
• Alves, G. G., R. A. M. De Ávila, C. D. Chávez-Olórtegui, and F. C. F. Lobato. 2014. “Clostridium perfringens Epsilon Toxin: The Third Most Potent Bacterial Toxin Known.” Anaerobe 30: 102–107. https://doi.org/10.1016/j.anaerobe.2014.08.016
   PubMed Web of Science ®Google Scholar
• Angsantikul, P., S. Thamphiwatana, W. Gao, and L. Zhang. 2015. “Cell Membrane-Coated Nanoparticles as an Emerging Antibacterial Vaccine Platform.” Vaccines 3 (4): 814–828. https://doi.org/10.3390/vaccines3040814
   Google Scholar
• Blanch, M., J. Dorca-Arévalo, A. Not, M. Cases, I. Gomez De Aranda, A. Martínez-Yélamos, S. Martínez-Yélamos, C. Solsona, and J. Blasi. 2018. “The Cytotoxicity of Epsilon Toxin from Clostridium perfringens on Lymphocytes is Mediated by MAL Protein Expression.” Molecular and Cellular Biology 38 (19): e00086-18. https://doi.org/10.1128/MCB.00086-18
   PubMed Web of Science ®Google Scholar
• Chou, L. Y., K. Ming, and W. C. Chan. 2011. “Strategies for the Intracellular Delivery of Nanoparticles.” Chemical Society Reviews 40 (1): 233–245. https://doi.org/10.1039/c0cs00003e
   PubMed Web of Science ®Google Scholar
• Cui, Y., J. Sun, W. Hao, M. Chen, Y. Wang, F. Xu, and C. Gao. 2020. “Dual-Target Peptide-Modified Erythrocyte Membrane-Enveloped PLGA Nanoparticles for the Treatment of Glioma.” Frontiers in Oncology 10: 563938. https://doi.org/10.3389/fonc.2020.563938
   PubMed Web of Science ®Google Scholar
• Curley, S. M., and D. Putnam. 2022. “Biological Nanoparticles in Vaccine Development.” Frontiers in Bioengineering and Biotechnology 10: 867119. https://doi.org/10.3389/fbioe.2022.867119
   PubMed Web of Science ®Google Scholar
• Derman, S., Z. A. Mustafaeva, E. S. Abamor, M. Bagirova, and A. Allahverdiyev. 2015. “Preparation, Characterization and Immunological Evaluation: Canine Parvovirus Synthetic Peptide Loaded PLGA Nanoparticles.” Journal of Biomedical Science 22 (1): 89. https://doi.org/10.1186/s12929-015-0195-2
   PubMedGoogle Scholar
• Elmowafy, E. M., M. Tiboni, and M. E. Soliman. 2019. “Biocompatibility, Biodegradation and Biomedical Applications of Poly (Lactic Acid)/Poly (Lactic-co-Glycolic Acid) Micro and Nanoparticles.” Journal of Pharmaceutical Investigation 49 (4): 347–380. https://doi.org/10.1007/s40005-019-00439-x
   Google Scholar
• Elsewedy, H. S., B. E. A. Dhubiab, M. A. Mahdy, and H. M. Elnahas. 2020. “Development, Optimization, and Evaluation of PEGylated Brucine-Loaded PLGA Nanoparticles.” Drug Delivery 27 (1): 1134–1146. https://doi.org/10.1080/10717544.2020.1797237
   PubMed Web of Science ®Google Scholar
• Fang, R. H., A. V. Kroll, W. Gao, and L. Zhang. 2018. “Cell Membrane Coating Nanotechnology.” Advanced Materials 30 (23): 1706759. https://doi.org/10.1002/adma.201706759
   PubMed Web of Science ®Google Scholar
• Fang, R. H., B. T. Luk, C.-M. J. Hu, and L. Zhang. 2015. “Engineered Nanoparticles Mimicking Cell Membranes for Toxin Neutralization.” Advanced Drug Delivery Reviews 90: 69–80. https://doi.org/10.1016/j.addr.2015.04.001
   PubMed Web of Science ®Google Scholar
• Farkhani, S. M., A. Valizadeh, H. Karami, S. Mohammadi, N. Sohrabi, and F. Badrzadeh. 2014. “Cell Penetrating Peptides: Efficient Vectors for Delivery of Nanoparticles, Nanocarriers, Therapeutic and Diagnostic Molecules.” Peptides 57: 78–94. https://doi.org/10.1016/j.peptides.2014.04.015
   PubMed Web of Science ®Google Scholar
• Feczkó, T., J. Tóth, G. Dósa, and J. Gyenis. 2011. “Optimization of Protein Encapsulation in PLGA Nanoparticles.” Chemical Engineering and Processing: Process Intensification 50 (8): 757–765. https://doi.org/10.1016/j.cep.2011.06.008
   Web of Science ®Google Scholar
• Fernandes, H. P., C. L. Cesar, and M. D. L. Barjas-Castro. 2011. “Electrical Properties of the Red Blood Cell Membrane and Immunohematological Investigation.” Revista Brasileira de Hematologia e Hemoterapia 33 (4): 297–301. https://doi.org/10.5581/1516-8484.20110080
   PubMedGoogle Scholar
• Gao, Jie, Wenwen Xin, Jing Huang, Bin Ji, Shan Gao, Liang Chen, Lin Kang, et al. 2018. “Hemolysis in Human Erythrocytes by Clostridium perfringens Epsilon Toxin Requires Activation of P2 Receptors.” Virulence 9 (1): 1601–1614. https://doi.org/10.1080/21505594.2018.1528842
   PubMed Web of Science ®Google Scholar
• Gao, W., and L. Zhang. 2015. “Engineering Red‐Blood‐Cell‐Membrane-Coated Nanoparticles for Broad Biomedical Applications.” AIChE Journal 61 (3): 738–746.
   Web of Science ®Google Scholar
• Gao, W., C. M. J. Hu, R. H. Fang, B. T. Luk, J. Su, and L. Zhang. 2013. “Surface Functionalization of Gold Nanoparticles with Red Blood Cell Membranes.” Advanced Materials (Deerfield Beach, Fla.) 25 (26): 3549–3553. https://doi.org/10.1002/adma.201300638
   PubMed Web of Science ®Google Scholar
• Guido, C., G. Maiorano, C. Gutiérrez-Millán, B. Cortese, A. Trapani, S. D’amone, G. Gigli, and I. E. Palamà. 2021. “Erythrocytes and Nanoparticles: New Therapeutic Systems.” Applied Sciences 11 (5): 2173. https://doi.org/10.3390/app11052173
   Google Scholar
• Hines, D. J., and D. L. Kaplan. 2013. “Poly (Lactic-co-Glycolic) Acid-Controlled-Release Systems: Experimental and Modeling Insights.” Critical Reviews in Therapeutic Drug Carrier Systems 30 (3): 257–276.
   PubMed Web of Science ®Google Scholar
• Horvath, D., and M. Basler. 2023. “PLGA Particles in Immunotherapy.” Pharmaceutics 15 (2): 615. https://doi.org/10.3390/pharmaceutics15020615
   PubMed Web of Science ®Google Scholar
• Hu, C.-M. J., and L. Zhang. 2014. “Nanotoxoid Vaccines.” Nano Today 9 (4): 401–404. https://doi.org/10.1016/j.nantod.2014.06.001
   PubMed Web of Science ®Google Scholar
• Hu, C.-M. J., L. Zhang, S. Aryal, C. Cheung, R. H. Fang, and L. Zhang. 2011. “Erythrocyte Membrane-Camouflaged Polymeric Nanoparticles as a Biomimetic Delivery Platform.” Proceedings of the National Academy of Sciences of the United States of America 108 (27): 10980–10985. https://doi.org/10.1073/pnas.1106634108
   PubMed Web of Science ®Google Scholar
• Hu, C.-M. J., R. H. Fang, B. T. Luk, and L. Zhang. 2013. “Nanoparticle-Detained Toxins for Safe and Effective Vaccination.” Nature Nanotechnology 8 (12): 933–938. https://doi.org/10.1038/nnano.2013.254
   PubMed Web of Science ®Google Scholar
• Jorge, S., and O. A. Dellagostin. 2017. “The Development of Veterinary Vaccines: A Review of Traditional Methods and Modern Biotechnology Approaches.” Biotechnology Research and Innovation 1 (1): 6–13. https://doi.org/10.1016/j.biori.2017.10.001
   Google Scholar
• Kang, T., C. Li, T. Du, Y. Wu, Y. Yang, X. Liu, Q. Zhang, X. Xu, and M. Gou. 2018. “A Biomimetic Nanoparticle-Enabled Toxoid Vaccine Against Melittin.” International Journal of Nanomedicine 13: 3251–3261. https://doi.org/10.2147/IJN.S156346
   PubMed Web of Science ®Google Scholar
• Keum, C.-G., Y.-W. Noh, J.-S. Baek, J.-H. Lim, C.-J. Hwang, Y.-G. Na, S.-C. Shin, and C.-W. Cho. 2011. “Practical Preparation Procedures for Docetaxel-Loaded Nanoparticles Using Polylactic Acid-co-Glycolic Acid.” International Journal of Nanomedicine 6: 2225–2234. https://doi.org/10.2147/IJN.S24547
   PubMed Web of Science ®Google Scholar
• Kim, S. H., J. H. Jeong, K. W. Chun, and T. G. Park. 2005. “Target-Specific Cellular Uptake of PLGA Nanoparticles Coated with Poly (l-Lysine)–Poly (Ethylene Glycol)–Folate Conjugate.” Langmuir 21 (19): 8852–8857. https://doi.org/10.1021/la0502084
   PubMed Web of Science ®Google Scholar
• Lee, S. Y., and H.-J. Cho. 2017. “Dopamine-Conjugated Poly (Lactic-co-Glycolic Acid) Nanoparticles for Protein Delivery to Macrophages.” Journal of Colloid and Interface Science 490: 391–400. https://doi.org/10.1016/j.jcis.2016.11.078
   PubMed Web of Science ®Google Scholar
• Li, H., K. Jin, M. Luo, X. Wang, X. Zhu, X. Liu, T. Jiang, Q. Zhang, S. Wang, and Z. Pang. 2019. “Size Dependency of Circulation and Biodistribution of Biomimetic Nanoparticles: Red Blood Cell Membrane-Coated Nanoparticles.” Cells 8 (8): 881. https://doi.org/10.3390/cells8080881
   PubMed Web of Science ®Google Scholar
• Madani, F., S. S. Esnaashari, B. Mujokoro, F. Dorkoosh, M. Khosravani, and M. Adabi. 2018. “Investigation of Effective Parameters on Size of Paclitaxel Loaded PLGA Nanoparticles.” Advanced Pharmaceutical Bulletin 8 (1): 77–84. https://doi.org/10.15171/apb.2018.010
   PubMed Web of Science ®Google Scholar
• Makadia, H. K., and S. J. Siegel. 2011. “Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.” Polymers 3 (3): 1377–1397. https://doi.org/10.3390/polym3031377
   PubMed Web of Science ®Google Scholar
• Malhotra, S., S. Dumoga, P. Sirohi, and N. Singh. 2019. “Red Blood Cells-Derived Vesicles for Delivery of Lipophilic Drug Camptothecin.” ACS Applied Materials & Interfaces 11 (25): 22141–22151. https://doi.org/10.1021/acsami.9b04827
   PubMed Web of Science ®Google Scholar
• Mander, K. A., F. A. Uzal, R. Williams, and J. W. Finnie. 2020. “Clostridium perfringens Type D Epsilon Toxin Produces a Rapid and Dose-Dependent Cytotoxic Effect on Cerebral Microvascular Endothelial Cells In Vitro.” Journal of Veterinary Diagnostic Investigation 32 (2): 277–281. https://doi.org/10.1177/1040638719882745
   PubMed Web of Science ®Google Scholar
• Moarref, M. P., M. K. Koohi, M. Alimolaei, T. Emami, and J. Hassan. 2022. “A New Practical Purification Method for Type D Clostridium perfringens Epsilon Toxin by Size-Exclusion Chromatography (SEC) and Ultrafiltration (UF).” Iranian Journal of Veterinary Medicine 16: 179.
   Google Scholar
• Morales-Cruz, M., G. M. Flores-Fernández, M. Morales-Cruz, E. A. Orellano, J. A. Rodriguez-Martinez, M. Ruiz, and K. Griebenow. 2012. “Two-Step Nanoprecipitation for the Production of Protein-Loaded PLGA Nanospheres.” Results in Pharma Sciences 2: 79–85. https://doi.org/10.1016/j.rinphs.2012.11.001
   PubMedGoogle Scholar
• Nejati, S., E. M. Vadeghani, S. Khorshidi, and A. Karkhaneh. 2020. “Role of Particle Shape on Efficient and Organ-Based Drug Delivery.” European Polymer Journal 122: 109353. https://doi.org/10.1016/j.eurpolymj.2019.109353
   Web of Science ®Google Scholar
• Nicolete, R., D. F. Dos Santos, and L. H. Faccioli. 2011. “The Uptake of PLGA Micro or Nanoparticles by Macrophages Provokes Distinct In Vitro Inflammatory Response.” International Immunopharmacology 11 (10): 1557–1563. https://doi.org/10.1016/j.intimp.2011.05.014
   PubMed Web of Science ®Google Scholar
• Niikura, Kenichi, Tatsuya Matsunaga, Tadaki Suzuki, Shintaro Kobayashi, Hiroki Yamaguchi, Yasuko Orba, Akira Kawaguchi, et al. 2013. “Gold Nanoparticles as a Vaccine Platform: Influence of Size and Shape on Immunological Responses In Vitro and In Vivo.” ACS Nano 7 (5): 3926–3938. https://doi.org/10.1021/nn3057005
   PubMed Web of Science ®Google Scholar
• Pati, R., M. Shevtsov, and A. Sonawane. 2018. “Nanoparticle Vaccines Against Infectious Diseases.” Frontiers in Immunology 9: 2224. https://doi.org/10.3389/fimmu.2018.02224
   PubMed Web of Science ®Google Scholar
• Que, X., J. Su, P. Guo, Z. Kamal, E. Xu, S. Liu, J. Chen, and M. Qiu. 2019. “Study on Preparation, Characterization and Multidrug Resistance Reversal of Red Blood Cell Membrane-Camouflaged Tetrandrine-Loaded PLGA Nanoparticles.” Drug Delivery 26 (1): 199–207. https://doi.org/10.1080/10717544.2019.1573861
   PubMed Web of Science ®Google Scholar
• Rezvantalab, S., N. I. Drude, M. K. Moraveji, N. Güvener, E. K. Koons, Y. Shi, T. Lammers, and F. Kiessling. 2018. “PLGA-Based Nanoparticles in Cancer Treatment.” Frontiers in Pharmacology 9: 1260. https://doi.org/10.3389/fphar.2018.01260
   PubMed Web of Science ®Google Scholar
• Sharma, L., W. Wu, S. L. Dholakiya, S. Gorasiya, J. Wu, R. Sitapara, V. Patel, M. Wang, M. Zur, and S. Reddy. 2014. “Assessment of Phagocytic Activity of Cultured Macrophages Using Fluorescence Microscopy and Flow Cytometry.” Methods in Molecular Biology 1172, 137–145.
   PubMedGoogle Scholar
• Stiles, B. G., G. Barth, H. Barth, and M. R. Popoff. 2013. “Clostridium perfringens Epsilon Toxin: A Malevolent Molecule for Animals and Man?” Toxins 5 (11): 2138–2160. https://doi.org/10.3390/toxins5112138
   PubMed Web of Science ®Google Scholar
• Su, J., G. Liu, Y. Lian, Z. Kamal, X. Que, Y. Qiu, and M. Qiu. 2018. “Preparation and Characterization of Erythrocyte Membrane Cloaked PLGA/Arsenic Trioxide Nanoparticles and Evaluation of Their In Vitro Anti-Tumor Effect.” RSC Advances 8 (36): 20068–20076. https://doi.org/10.1039/c8ra01417e
   PubMed Web of Science ®Google Scholar
• Szeto, G. L., and E. B. Lavik. 2016. “Materials Design at the Interface of Nanoparticles and Innate Immunity.” Journal of Materials Chemistry B 4 (9): 1610–1618. https://doi.org/10.1039/C5TB01825K
   PubMed Web of Science ®Google Scholar
• Vincy, Antony, Sarmistha Mazumder, Amrita, Indranil Banerjee, Kuo Chu Hwang, Raviraj Vankayala. 2022. Recent Progress in Red Blood Cells-Derived Particles as Novel Bioinspired Drug Delivery Systems: Challenges and Strategies for Clinical Translation. Frontiers in Chemistry, 10, 905256. https://doi.org/10.3389/fchem.2022.905256
   PubMed Web of Science ®Google Scholar
• Wagley, Sariqa, Monika Bokori-Brown, Helen Morcrette, Andrea Malaspina, Caroline D'Arcy, Sharmilee Gnanapavan, Nicholas Lewis, et al. 2019. “Evidence of Clostridium perfringens Epsilon Toxin Associated with Multiple Sclerosis.” Multiple Sclerosis (Houndmills, Basingstoke, England) 25 (5): 653–660. https://doi.org/10.1177/1352458518767327
   PubMed Web of Science ®Google Scholar
• Walters, A. A., C. Krastev, A. V. Hill, and A. Milicic. 2015. “Next Generation Vaccines: Single-Dose Encapsulated Vaccines for Improved Global Immunisation Coverage and Efficacy.” Journal of Pharmacy and Pharmacology 67 (3): 400–408. https://doi.org/10.1111/jphp.12367
   PubMed Web of Science ®Google Scholar
• Waterborg, J. H. 2009. “The Lowry Method for Protein Quantitation.” In John M. Walker (Ed) The Protein Protocols Handbook, 7–10. Springer, England.
   Google Scholar
• Xuan, M., J. Shao, and J. Li. 2019. “Cell Membrane-Covered Nanoparticles as Biomaterials.” National Science Review 6 (3): 551–561. https://doi.org/10.1093/nsr/nwz037
   PubMed Web of Science ®Google Scholar
• Zhu, W., and J. Su. 2022. “Immune Functions of Phagocytic Blood Cells in Teleost.” Reviews in Aquaculture 14 (2): 630–646. https://doi.org/10.1111/raq.12616
   Web of Science ®Google Scholar